Valuation: Nephros, Inc.

Market Cap 40.82M 35.69M 32.94M 30.34M 57.22M 3.93B 58.48M 394M 155M 1.92B 153M 150M 6.63B P/E 2026 *
83.6x
P/E 2027 * 37.6x
Enterprise Value 40.82M 35.69M 32.94M 30.34M 57.22M 3.93B 58.48M 394M 155M 1.92B 153M 150M 6.63B EV / Sales 2026 *
1.94x
EV / Sales 2027 * 1.77x
Free-Float
87.13%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Nephros, Inc.

Manager TitleAgeSince
Chief Executive Officer 51 05/05/2023
Director of Finance/CFO 60 01/11/2023
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 69 19/09/2007
Director/Board Member 54 10/08/2018
Director/Board Member 58 08/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-1.69% - - 40.82M
-0.53%-5.05% - - 17.13B
-0.78%+2.12%+29.25%+46.18% 10.56B
-0.46%-5.21%+152.22%+518.65% 4.69B
-7.70%-6.50%+52.06%+260.08% 4.41B
-8.93%-29.96%+85.73%+90.39% 1.52B
-10.69%-6.73% - - 1.39B
-2.32%+1.40%-18.49%-9.98% 943M
-8.33%-16.78%+116.54%+114.47% 927M
-9.06%-11.52%+103.71%+113.81% 786M
Average -4.88%-3.47%+74.43%+161.94% 4.71B
Weighted average by Cap. -2.33%-2.05%+65.22%+184.21%

Financials

2026 *2027 *
Net sales 21.08M 18.43M 17.01M 15.67M 29.55M 2.03B 30.21M 203M 79.87M 994M 79.18M 77.43M 3.42B 23.13M 20.22M 18.66M 17.19M 32.42M 2.23B 33.13M 223M 87.61M 1.09B 86.85M 84.93M 3.75B
Net income 517K 452K 417K 384K 725K 49.77M 741K 4.99M 1.96M 24.37M 1.94M 1.9M 83.94M 1.19M 1.04M 962K 886K 1.67M 115M 1.71M 11.5M 4.52M 56.19M 4.48M 4.38M 194M
Net Debt - -
Logo Nephros, Inc.
Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-